a room full of top investors + 35 cracked founders = the best demo day some highlights from today: @spacemonqi is merging man with machine with psytech @zainmfj is building AI desktop assistants that do all your work across your mac @rsgharat is building precision missile

[FOR INVESTORS AND MEDIA] The FDA has granted Breakthrough Therapy designation to BPL-003 for treatment-resistant depression. This milestone validates our strong Phase 2b data and accelerates our path forwards to Phase 3. https://t.co/yCzoCiSn7I

atai Life Sciences and Beckley Psytech have announced the completion of their strategic combination, with the combined entity called AtaiBeckley.

Live product demos are so fun. Daniel from PsyTech playing virtual violin with haptic gloves at @theresidency demo day. Congrats to all the residents!

Psytech by Samuel Farrand 😍🤩 #psychedelic #trippy #artworks

Closer than you think. Keep going. ➡️ Double tap if you agree! ❤️ #Mindset #GoalGetter #SuccessQuotes #Psytech

Beckley Psytech’s 5-MeO-DMT Candidate Wins FDA Breakthrough Therapy Status Read more in Bulletin 211: https://t.co/OS8gDvYunE

#News: We’re thrilled to announce the successful completion of atai Life Sciences’ strategic combination with Beckley Psytech. Together, we are now AtaiBeckley, a global leader in transformative mental health therapies. Read the press release here:

Major news for mental health research — the FDA has granted Breakthrough Therapy status to a 5-MeO-DMT nasal spray developed by Atai Life Sciences and Beckley Psytech.

ATAI and Beckley Psytech reported positive Phase 2a results for BPL-003 in treatment-resistant depression. The study showed significant depression score reductions and improved remission rates, supporting Phase 3 trial plans. Psychedelics in clinical trials: Mental health

$ATAI just received FDA Breakthrough Therapy designation for its nasal spray BPL-003, developed with Beckley Psytech, targeting treatment-resistant depression. The designation is meant to fast-track development of drugs for serious conditions after promising Phase 2b results.

The show stopper for the day was PsyTech - it creates music notes & tracks based on hand gestures! Founders Inc pulled together a fantastic event - over 3K+ sign-ups and the floors were jam packed for a Friday evening. Even as I left at 7:30 PM, there was a long line to get

Psytech!!!

We're looking forward to sharing data on BPL-003 and SSRIs at the CNS Summit in Boston next week. Make sure to drop by to learn more. https://t.co/xoTOiyuNEL

We are excited to present data on BPL-003 and anhedonia at ECNP this weekend. Make sure to swing by to learn more! https://t.co/lrbixMgGAl

Need a new WEBSITE? 🌐 Our expert team crafts unique, user-friendly sites tailored to your specific needs. 🛠️ Let's build something great and grow your business! 🚀 Ready to get started? Call us now at +91 84830 98263! 📞 #WebDevelopment #NewWebsite #WebDesign #Psytech

I’m proud to share that atai Life Sciences and Beckley Psytech have joined forces to become @AtaiBeckley. Our mission is to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments. This is just the beginning. #MentalHealth

Visit our site to dive deeper into each strategy! 😊 https://t.co/uDUx0Ou8JO #DigitalMarketing #MarketingStrategy #ContentMarketing #SocialMediaMarketing #InfluencerMarketing #ViralAdvertising #EmailMarketing #AffiliateMarketing #Psytech

GH Research enjoying halo effect of Beckley Psytech's / atai Life Sciences' positive Phase 2b, with investors presumably believing the readout derisks the drug. $GHRS up 25% over past 5 days, identical to $ATAI.